BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novartis Pharma AG 

Lichtstrasse 35

Basel    CH-4002  Switzerland
Phone: 41-61-324-111 Fax: 41-61-324-8001


SEARCH JOBS




Industry
Pharmaceutical


Collaborations

Beyond Genomics, Inc. 

Emisphere Technologies, Inc.  Salmon calcitonin





 Company News
Proteus Digital Health, Inc. Grows Leadership Team And Board Of Directors With Former Executives From Novartis Pharma AG (NVS), Novartis Pharma AG (NVS) And Egreetings Network 4/16/2014 9:33:11 AM    More...
Unigene Laboratories, Inc. (UGNE) Announces Novartis Pharma AG (NVS)' Disclosure of First Interpretable Results from Phase 3 Trial of Calcitonin (SMC021) in the Treatment of Post-menopausal Osteoporosis 11/14/2011 7:08:13 AM    More...
Novartis Pharma AG (NVS) Selects Veeva Systems, Inc. CRM for Global Deployments 10/19/2010 10:41:35 AM    More...
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT 7/23/2010 7:08:08 AM    More...
Emisphere Technologies, Inc. (EMIS) Announces Expanded Collaboration Agreement With Novartis Pharma AG (NVS) and Cancellation of Convertible Promissory Note 6/4/2010 9:58:37 AM    More...
Titan Pharmaceuticals (TTP) Provides Estimate of Upcoming Royalty Payment 4/22/2010 10:51:38 AM    More...
Emisphere Technologies, Inc. (EMIS) Partner Initiates Second Phase I Trial for Oral PTH Therapy for the Treatment of Postmenopausal Osteoporosis 4/15/2010 9:55:23 AM    More...
Novartis Pharma AG (NVS) Reports Positive Results From Phase II LCZ696 Trial 3/17/2010 9:00:25 AM    More...
Emisphere Technologies, Inc. (EMIS) Announces Extension of Maturity Date for Novartis Pharma AG (NVS) Convertible Promissory Note 11/30/2009 9:11:56 AM    More...
Idenix Pharmaceuticals, Inc. (IDIX) Says Novartis Pharma AG (NVS) (JOBS) Not to License Hepatitis C Drug 10/30/2009 6:32:45 AM    More...
12345678910...